GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GM-CSF targeted immunomodulation affects host response to M. tuberculosis infection
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-30
DOI
10.1038/s41598-018-26984-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody
- (2018) Gerd R. Burmester et al. Arthritis & Rheumatology
- Role of Granulocyte-Macrophage Colony-Stimulating Factor Production by T Cells during Mycobacterium tuberculosis Infection
- (2017) Alissa C. Rothchild et al. mBio
- A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis
- (2017) Michael E. Weinblatt et al. Arthritis & Rheumatology
- Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery
- (2016) Gemma O'Connor et al. ADVANCED DRUG DELIVERY REVIEWS
- Anticytokine autoantibodies in infection and inflammation
- (2016) Gabriela Barcenas-Morales et al. Current Opinion in Allergy and Clinical Immunology
- Interleukin-35 Limits Anti-Tumor Immunity
- (2016) Meghan E. Turnis et al. IMMUNITY
- GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
- (2016) Burkhard Becher et al. IMMUNITY
- Type I IFN Inhibits Alternative Macrophage Activation duringMycobacterium tuberculosisInfection and Leads to Enhanced Protection in the Absence of IFN-γ Signaling
- (2016) Lúcia Moreira-Teixeira et al. JOURNAL OF IMMUNOLOGY
- Host-directed therapies for infectious diseases: current status, recent progress, and future prospects
- (2016) Alimuddin Zumla et al. LANCET INFECTIOUS DISEASES
- Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
- (2016) Noria Segueni et al. Scientific Reports
- Innate myeloid cell TNFR1 mediates first line defence against primary Mycobacterium tuberculosis infection.
- (2016) Noria Segueni et al. Scientific Reports
- Interdependence between Interleukin-1 and Tumor Necrosis Factor Regulates TNF-Dependent Control of Mycobacterium tuberculosis Infection
- (2015) Nelson C. Di Paolo et al. IMMUNITY
- Towards host-directed therapies for tuberculosis
- (2015) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria
- (2014) Kyungchul Kim et al. CYTOKINE
- Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis
- (2014) Roanne Keeton et al. JOURNAL OF CLINICAL INVESTIGATION
- Relative Levels of M-CSF and GM-CSF Influence the Specific Generation of Macrophage Populations during Infection with Mycobacterium tuberculosis
- (2014) D. M. Higgins et al. JOURNAL OF IMMUNOLOGY
- Metformin as adjunct antituberculosis therapy
- (2014) A. Singhal et al. Science Translational Medicine
- iNKT Cell Production of GM-CSF Controls Mycobacterium tuberculosis
- (2014) Alissa C. Rothchild et al. PLoS Pathogens
- Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis
- (2014) Keertan Dheda et al. Lancet Respiratory Medicine
- The Immune Response in Tuberculosis
- (2013) Anne O'Garra et al. Annual Review of Immunology
- Mycobacterium tuberculosis-induced expression of granulocyte-macrophage colony stimulating factor is mediated by PI3-K/MEK1/p38 MAPK signaling pathway
- (2013) Jang-Eun Cho et al. BMB Reports
- In Vitro Expression of IL-1α, GM-CSF, and TNF-α by Multinucleated Macrophages from BCG-Infected Mice
- (2013) D. A. Iljine et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- Anti-GM-CSF Autoantibodies in Patients with Cryptococcal Meningitis
- (2013) L. B. Rosen et al. JOURNAL OF IMMUNOLOGY
- Within the Enemy’s Camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis
- (2013) Christopher R. Shaler et al. Frontiers in Immunology
- Emerging Trends in the Formation and Function of Tuberculosis Granulomas
- (2013) Geanncarlo Lugo-Villarino et al. Frontiers in Immunology
- Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
- (2012) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas
- (2012) Ciaran Skerry et al. PLoS One
- Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor- , in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study
- (2011) G. R. Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology
- (2011) Zhenhua Yang et al. INFECTION GENETICS AND EVOLUTION
- Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection
- (2011) Catherine Uyttenhove et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Granulocyte–macrophage colony stimulating factor-mediated innate responses in tuberculosis
- (2007) Jacek Szeliga et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now